Nextage Therapeutics has developed a system that allows cannabis molecules to cross the blood-brain barrier (BBB) and reach the brain directly. The technology is based on research done at the Technion-Israel Institute of Technology and means that many side effects can be avoided and doses can be lowered in the medical use of cannabis.
Enabling the passage of medicine through the BBB could provide medical breakthroughs in a variety of treatments. Nextage’s new technology is tailored for use with cannabinoids but may provide insight into other uses. Nextage research showed that it is possible to pass a wide variety of chemicals through the BBB.
Passing medicine directly through the BBB could minimize side effects caused by treatments spreading in other organs, it could also lower necessary doses by increasing the bioavailability of the medicine delivered directly to the brain.
Nextage will patent the new technology and will begin negotiating with companies interested in…